Introduction
Approximately 20,000 to 30,000 patients with mea sles have been reported annually in the Infectious Dis ease Surveillance in Japan.1 This number represents only reported cases at fixed points of observation and thus, 200,000 individuals are predicted to be infected with measles in present epidemics. Recent studies of measles tend to increase the number of patients with secondary vaccine failure (SVF).2.3 They demonstrate that SVF cases are caused by completely waning immunity in recipients of the further attenuated live measles vaccines. From this point of view, seroepide miological study is required. Miyamura et al4 reports the seroepidemiology of measles by the standard hemagglutination inhibition (HI) antibody and newly developed gelatin particle agglutination (PA) antibody. They report that 206 (52.2%) of the 395 HI negative sera were PA positive and suppose that PA assay could detect not only HI antibody but also antifusion protein antibody. Neutralizing test (NT) antibody is more sen sitive than HI antibody test,' but the assay of NT anti 
Discussion
There are a few fundamental approaches in how to inoculate measles virus vaccine. 6, 7 On the basis of these approaches, a two dose schedule of measles, mumps, and rubella vaccine is conducted in the USA and many countries of Europe. In the USA, the first dose is given to children aged 12 to 15 months, and the second dose follows at the age of 4 to 6 years.
Further attenuated measles vaccines have been used in routine immunization in Japan, since 1978, when the immunization schedule by age was defined as 12 to 72 months, and in April 1995 it was amended as 12 to 90 months. Owing to this measles immunization schedule, the epidemic of measles has been decreasing, but at present, we still have measles patients because only 73% of all infants receive measles vaccine on average in Japan. In Urawa City the vaccine coverage of measles was 73.7 to 88.0% (84.4% on average) in school chil dren during the past 10 years.
In general, over 95% of vaccine coverage is required for the prevention of epidemics. For control of an infectious disease, knowing how many in the population are susceptible is crucial. There is no available seroepi demiological data based upon NT antibody assay at present. In this study, we examined the presence of HI antibodies in 1591 serum samples and further analyzed NT antibody in 497 HI negative sera. Four hundred nineteen (84.3%) of 497 HI negative sera were positive in the NT test. We further investigated NT antibody in 103 sera which showed 1:8, borderline positive HI antibody titer, and all were positive for NT antibody. Thus, HI positives were considered as evidence of immune status.
Our method of screening using the HI test is prac tical and reliable for a fairly large-scale seroepidemio logical study. Most HI negatives were NT positive in this study, and more than 90% of the individuals over three years of age had immune status. The positive rate of HI antibody differed from 56% in the group aged 12 years and 68.2% in that aged 9 years. After 12 years of age, the positive rate of HI increased to 65.3% in the group aged 13 to 15 years and to 72.7% in the group aged 15 to 20 years. Increase in the positive rate of HI antibody reflects the repetitious natural booster effect in the community.
Finally, almost all adolescents over 15 years of age and adults had HI and/or NT antibodies. Our sero logical study is limited to the particular period of 1994 and 1995. But it is obvious that approximately 5% of school age children (from 6 to 15 years) remain sus ceptible to measles. Most of these children have no history of immunization, which becomes an impediment to control of measles. Judging from the results of this study, and taken together with the reports of increased numbers of secondary vaccine failures observed approximately 10 years after vaccination,2,3 we spec ulate that the most effective way to decrease measles epidemics is (1) to increase the vaccine coverage of the first dose at 1 year of age, and (2) to implement a sec ond inoculation at a certain age (before entrance to elementary or junior high school).
